Company Overview and News

 
Aluminum Stash Visible From Space Turned to Gold for This Trader - Bloomberg

20h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Why Commodity Stocks Surged on April 18—All You Need to Know

2018-04-19 marketrealist
April 18, 2018, belonged to commodity stocks (COMT), some of which saw their highest one-day gains in months. Among the iron ore and diversified companies, Glencore (GLNCY) surged 7.7%, and Anglo American (AAUKY) saw price gains of 6.2%. BHP Billiton (BHP), Rio Tinto (RIO), Vale SA (VALE), and Cleveland-Cliffs (CLF) rose 3.3%, 4.0%, 4.2%, and 4.4%, respectively.
Upvote Downvote

 
De Beers Has a Clean-Up Plan for Blood Diamonds - Bloomberg

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Market report: Miners drive FTSE to 10-week high

2018-04-18 telegraph.co.uk
London's mining giants propelled the FTSE 100 to a 10-week high as the fallout from US sanctions gripped metal markets, analysts predicted a huge surge in aluminium prices and Glencore’s long-standing interest in Bunge was being speculated on by chattering traders.
Upvote Downvote

 
ASX to lift on surging oil and metal prices, Wall Street falters

2018-04-18 abc.net.au
The Australian share market is expected to begin the day stronger, after a surge in metal and oil prices overnight — even as Wall Street's rally began to deflate.
Upvote Downvote

 
VINCI : Assemblée générale du 17 avril 2018

2018-04-17 globenewswire
L'assemblée générale mixte des actionnaires de VINCI s'est réunie le 17 avril 2018 à la Salle Pleyel à Paris, sous la présidence de Xavier Huillard, président-directeur général du Groupe. Le quorum s'est établi à 58,99% et l'assemblée générale a approuvé l'ensemble des résolutions qui lui étaient soumises.
Upvote Downvote

 
VINCI : Shareholders' General Meeting of 17 April 2018

2018-04-17 globenewswire
VINCI's Combined Shareholders' General Meeting, chaired by Xavier Huillard, the Group's Chairman and Chief Executive Officer, was held on 17 April 2018 at the Salle Pleyel in Paris. The quorum was 58.99% and the shareholders' meeting approved all the resolutions submitted.
Upvote Downvote

 
Los Angeles Times Confirms Our Reporting on CalPERS CFO Charles Asubonten's Resume Misrepresentations; CalPERS Admits to Fabrications and Gets Defensive | naked capitalism

2018-04-17 nakedcapitalism
The Los Angles Times’ Pulitzer-Prize-winning reporter Mike Hiltzik confirmed our reporting on the misrepresentations and discrepancies in the resume of recently-hired CalPERS Chief Financial Officer Charles Asubonten and called on the board to investigate. If you managed to miss the series, you can find the links to them at the end of this post.
Upvote Downvote

 
A Look At The Junior Cobalt Miners In Early 2018

2018-04-17 seekingalpha
This article first appeared on Trend Investing on February 16, therefore all data is as of that date.
Upvote Downvote

 
UPDATE 1-UK Stocks-Factors to watch on April 17

2018-04-17 reuters
April 17 (Reuters) - Britain’s FTSE 100 index is seen opening 14 points higher at 7,212 on Tuesday, according to financial bookmakers, with futures up 0.1 pct ahead of the cash market open.
Upvote Downvote

1
Vedanta Resources poaches boss of AngloGold Ashanti as new boss

2018-04-16 telegraph.co.uk
Mining group Vedanta has poached the boss of AngloGold Ashanti for its new chief executive, filling a role that has been vacant for a year.
Upvote Downvote

1
Anil Agarwal hires AngloGold’s Srinivasan Venkatakrishnan as Vedanta CEO

2018-04-16 livemint
Nairobi/London: Indian billionaire Anil Agarwal’s Vedanta Resources Plc. named AngloGold Ashanti Ltd’s Srinivasan Venkatakrishnan as its new chief executive officer (CEO) as the diversified miner ended a year-long search for a new boss.
Upvote Downvote

 
Central Queensland community left powerless after mining road blast

2018-04-16 abc.net.au
A Central Queensland community that lost access to a vital road after a routine mine blast has been told the road is unfixable and the only option is a new road on a new route.
Upvote Downvote

 
Anil Agarwal offers Anglo American help in tapping India’s 1.3 billion people

2018-04-12 livemint
Johannesburg/London: Anglo American Plc’s biggest shareholder, billionaire Anil Agarwal, has offered to help the mining giant expand into India.
Upvote Downvote

 
Mining industry must improve human rights, environment protection, says index

2018-04-11 themalaymailonline
Mining practices have often been criticised for not taking into account worker safety. — AFP picLONDON, April 11 — The world’s biggest mining companies must improve their human rights record and step up efforts to curb environmental damage, the Responsible Mining Foundation said in its first review of global mining practices.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...